{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:05:57Z","timestamp":1781787957085,"version":"3.54.5"},"reference-count":31,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T00:00:00Z","timestamp":1743292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH","award":["5U01 TR002764"],"award-info":[{"award-number":["5U01 TR002764"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Background: The human brain relies on complex synaptic communication regulated by key genes such as SYNGAP1. SYNGAP1 encodes the GTPase-Activating Protein (SYNGAP), a critical synaptic plasticity and neuronal excitability regulator. Impaired SYNGAP1 function leads to neurodevelopmental disorders (NDDs) characterized by intellectual disability (ID), epilepsy, and behavioral abnormalities. These variants disrupt Ras signaling, altering AMPA receptor transport and synaptic plasticity and contributing to cognitive and motor difficulties. Despite advancements, challenges remain in defining genotype\u2013phenotype correlations and distinguishing SYNGAP1-related disorders from other NDDs, which could improve underdiagnosis and misdiagnosis. Brain Gene Registry: The Brain Gene Registry (BGR) was established as a collaborative initiative, consolidating genomic and phenotypic data across multiple research centers. This database allows for extensive analyses, facilitating improved diagnostic accuracy, earlier interventions, and targeted therapeutic strategies. The BGR enhances our understanding of rare genetic conditions and is critical for advancing research on SYNGAP1-related disorders. Conclusions: While no FDA-approved treatments exist for SYNGAP1-related disorders, several therapeutic approaches are being investigated. These include taurine supplementation, ketogenic diets, and molecular strategies such as antisense oligonucleotide therapy to restore SYNGAP1 expression. Behavioral and rehabilitative interventions remain key for managing developmental and cognitive symptoms. Advancing research through initiatives like the BGR is crucial for refining genotype\u2013phenotype associations and developing precision medicine approaches. A comprehensive understanding of SYNGAP1-related disorders will improve clinical outcomes and patient care, underscoring the need for continued interdisciplinary collaboration in neurodevelopmental genetics.<\/jats:p>","DOI":"10.3390\/genes16040405","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T05:10:07Z","timestamp":1743397807000},"page":"405","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["SYNGAP1 Syndrome and the Brain Gene Registry"],"prefix":"10.3390","volume":"16","author":[{"given":"Melissa R.","family":"Greco","sequence":"first","affiliation":[{"name":"Division of Neurogenetics and Neurodevelopmental Pediatrics, Children\u2019s National Hospital, Washington, DC 20010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"Division of Neurogenetics and Neurodevelopmental Pediatrics, Children\u2019s National Hospital, Washington, DC 20010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9868-804X","authenticated-orcid":false,"given":"Alexa M.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Division of Neurogenetics and Neurodevelopmental Pediatrics, Children\u2019s National Hospital, Washington, DC 20010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.","family":"Gropman","sequence":"additional","affiliation":[{"name":"Division of Neurogenetics and Neurodevelopmental Pediatrics, Children\u2019s National Hospital, Washington, DC 20010, USA"},{"name":"St. Jude Children\u2019s Research Hospital, Memphis, TN 38105, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Jeyabalan, N., and Clement, J.P. (2016). SYNGAP1: Mind the Gap. Front. Cell. Neurosci., 10.","DOI":"10.3389\/fncel.2016.00032"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/scientificamerican0979-44","article-title":"The Brain","volume":"241","author":"Hubel","year":"1979","journal-title":"Sci. Am."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijdevneu.2019.08.003","article-title":"SYNGAP1 mutations: Clinical, genetic, and pathophysiological features","volume":"78","author":"Agarwal","year":"2019","journal-title":"Int. J. Dev. Neurosci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0896-6273(00)80471-7","article-title":"A synaptic Ras-GTPase activating protein (p135 SynGAP) inhibited by CaM kinase II","volume":"20","author":"Chen","year":"1998","journal-title":"Neuron"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0896-6273(00)81008-9","article-title":"SynGAP: A Synaptic RasGAP that associates with the PSD-95\/SAP90 protein family","volume":"20","author":"Kim","year":"1998","journal-title":"Neuron"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1523\/JNEUROSCI.0420-19.2020","article-title":"Twenty Years of SynGAP Research: From Synapses to Cognition","volume":"40","author":"Gamache","year":"2020","journal-title":"J. Neurosci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"eadk1291","DOI":"10.1126\/science.adk1291","article-title":"SynGAP regulates synaptic plasticity and cognition independently of its catalytic activity","volume":"383","author":"Araki","year":"2024","journal-title":"Science"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s11689-024-09530-3","article-title":"The Brain Gene Registry: A data snapshot","volume":"16","author":"Baldridge","year":"2024","journal-title":"J. Neurodev. Disord."},{"key":"ref_9","first-page":"101035","article-title":"Clinical variants paired with phenotype: A rich resource for brain gene curation","volume":"26","author":"Chopra","year":"2024","journal-title":"Anesth. Analg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cell.2017.06.009","article-title":"RAS proteins and their regulators in human disease","volume":"170","author":"Simanshu","year":"2017","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa0805392","article-title":"Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation","volume":"360","author":"Hamdan","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_12","unstructured":"Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., Bean, L.J.H., Gripp, K.W., and Amemiya, A. (2025, January 15). SYNGAP1-Related Intellectual Disability, GeneReviews\u00ae, Available online: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30789692."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s11689-018-9225-1","article-title":"The first international conference on SYNGAP1-related brain disorders: A stakeholder meeting of families, researchers, clinicians, and regulators","volume":"10","author":"Weldon","year":"2018","journal-title":"J. Neurodev. Disord."},{"key":"ref_14","first-page":"25","article-title":"Correlation of early neurodevelopmental features of children with SYNGAP1 variants and their genotypes","volume":"41","author":"Liu","year":"2024","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chin. J. Med. Genet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/jmedgenet-2015-103451","article-title":"Genetic and neurodevelopmental spectrum of SYNGAP1-associated intellectual disability and epilepsy","volume":"53","author":"Mignot","year":"2016","journal-title":"J. Med Genet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s11689-019-9276-y","article-title":"Phenotypic characterization of individuals with SYNGAP1 pathogenic variants reveals a potential correlation between posterior dominant rhythm and developmental progression","volume":"11","author":"Niu","year":"2019","journal-title":"J. Neurodev. Disord."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/ng.2646","article-title":"Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1","volume":"45","author":"Carvill","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/epi.17913","article-title":"Comprehensive phenotypes of patients with SYNGAP1-related disorder reveals high rates of epilepsy and autism","volume":"65","author":"Wiltrout","year":"2024","journal-title":"Epilepsia"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s11689-022-09437-x","article-title":"Clinical and behavioural features of SYNGAP1-related intellectual disability: A parent and caregiver description","volume":"14","author":"Wright","year":"2022","journal-title":"J. Neurodev. Disord."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41593-018-0268-0","article-title":"SYNGAP1 heterozygosity disrupts sensory processing by reducing touch-related activity within somatosensory cortex circuits","volume":"21","author":"Michaelson","year":"2018","journal-title":"Nat. Neurosci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1089\/cap.2024.0055","article-title":"SYNGAP-1 Mutation And Catatonia: A Case Series and Systematic Review","volume":"34","author":"Baldwin","year":"2024","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e200105","DOI":"10.1212\/NXG.0000000000200105","article-title":"Adult Phenotype of SYNGAP1-DEE","volume":"9","author":"Rong","year":"2023","journal-title":"Neurol. Genet."},{"key":"ref_23","first-page":"S1","article-title":"The unexpected and novel mitochondrial phenotype of the ex vivo patient-derived cellular model for SYNGAP1 encephalopathy [CNS Annual Meeting abstract PL2-6]","volume":"96","author":"Greco","year":"2024","journal-title":"Ann. Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1111\/epi.16972","article-title":"Dietary medium chain triglycerides for management of epilepsy: New data from human, dog, and rodent studies","volume":"62","author":"Han","year":"2021","journal-title":"Epilepsia"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1038\/s41467-023-38273-3","article-title":"Mapping PTBP2 binding in human brain identifies SYNGAP1 as a target for therapeutic splice switching","volume":"14","author":"Felix","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Gupta, S., Hwang, Y., Ludwig, N., Henry, J., and Kadam, S.D. (2023). Case report: Off-label use of low-dose perampanel in a 25-month-old girl with a pathogenic SYNGAP1 variant. Front. Neurol., 14.","DOI":"10.3389\/fneur.2023.1221161"},{"key":"ref_27","unstructured":"Syngap Research Fund (2025, February 07). Cure Syngap1. Available online: https:\/\/curesyngap1.org\/blog\/syngap-research-funds-2024-syngap1-science-conference-collaboration-and-progress-on-our-road-to-cure-syngap1\/."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41588-022-01027-w","article-title":"A call for an integrated approach to improve efficiency, equity and sustainability in rare disease research in the United States","volume":"54","author":"Halley","year":"2022","journal-title":"Nat. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Cordova, I., Blesson, A., Savatt, J.M., Sveden, A., Mahida, S., Hazlett, H., Riggs, E.R., and Chopra, M. (2024). Brain Gene Registry Subset of the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel. Expansion of the Genotypic and Phenotypic Spectrum of ASH1L-Related Syndromic Neurodevelopmental Disorder. Genes, 15.","DOI":"10.3390\/genes15040423"},{"key":"ref_30","unstructured":"UNIT K (2017). CCRP: Minimally Disruptive Research: A Respectful Approach to Conducting Clinical Studies, The Knowledge and Evaluation Research Unit at Mayo Clinic."},{"key":"ref_31","unstructured":"Screening Consent (2025, March 22). National Brain Gene Registry. Available online: https:\/\/braingeneregistry.wustl.edu\/screening-consent\/."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/16\/4\/405\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:06:00Z","timestamp":1760029560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/16\/4\/405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,30]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["genes16040405"],"URL":"https:\/\/doi.org\/10.3390\/genes16040405","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,30]]}}}